• 1
  • 2
  • 3
  • 4
  • 5
Annual Report
DOM Women's Committee newsletter
Eileen Dolan, PhD
Robert Grossman, PhD
Precision Medicine

 
 

NEWS

  • George Bakris, MD

    Investigational drug prevents life-threatening side effects of kidney disease treatment

    A yearlong study of more than 300 patients found that the investigational drug patiromer can reduce elevated blood-potassium levels -- a common side effect of drugs essential in the treatment of chronic diabetic kidney disease.

    More...

  • Kate Thompson, MD

    Kate Thompson ,MD receives HRSA award to support quality care for older adults

    Kate Thompson, MD, Assistant Professor of Medicine (Geriatrics & Palliative Medicine) is the recipient of Geriatrics Workforce Enhancement Program (GWEP) award from HRSA. The University of Chicago, Department of Medicine is one of 44 recipients of this prestigious award to help build the aging workforce on Chicago's South Side.

    More...

  • Louis Philipson, MD, PhD

    Could insulin pills prevent diabetes? Big study seeks answer

    CHICAGO (AP) -- For nearly a century, insulin has been a life-saving diabetes treatment. Now scientists are testing a tantalizing question: What if pills containing the same medicine patients inject every day could also prevent the disease?

    More...

  • Bana Jabri, MD PhD

    The Myth of Big, Bad Gluten

    AS many as one in three Americans tries to avoid gluten, a protein found in wheat, barley and rye. Gluten-free menus, gluten-free labels and gluten-free guests at summer dinners have proliferated.

    Some of the anti-glutenists argue that we haven't eaten wheat for long enough to adapt to it as a species. Agriculture began just 12,000 years ago, not enough time for our bodies, which evolved over millions of years, primarily in Africa, to adjust. According to this theory, we're intrinsically hunter-gatherers, not bread-eaters. If exposed to gluten, some of us will develop celiac disease or gluten intolerance, or we'll simply feel lousy.

    More...

  • 2015 DOM Award Winners

    At the Department of Medicine 's 10th Annual Award Celebration held on Tuesday, June 23,2015, Dr. Everett Vokes recognized the following faculty for their outstanding contributions as teachers, clinicians, mentors and scientists.

    More...

  • Pembrolizumab shows real promise against head and neck cancer

    Biomarker reliably predicts which patients will not benefit

    Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda®) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American Society for Clinical Oncology (ASCO).

    Pembrolizumab decreased the size of tumors by 30 percent or more in 24.8 percent of 132 patients, making it nearly twice as effective as the current preferred treatment using platinum-based chemotherapy plus cetuximab, an epidermal growth factor inhibitor.

    More...

  • Website educates cancer patients about the costs of care

    Cancer, all by itself, is bad enough. Although cancer treatment, especially chemotherapy, has become much gentler than it was a decade ago, most interventions still carry significant risks and side effects.

    Recently, many physicians have focused on a different sort of hazard that they call “financial toxicity.” Along with the distress of a cancer diagnosis and the discomforts of treatment, patients increasingly have to deal with the cost, anxiety and loss of confidence inspired by large, unpredictable expenses, often compounded by decreased ability to work.

     

    More...

  • Dan Nicolae, MD

    GTEx findings reveal new insights into how DNA differences influence gene activity, disease susceptibility

    Researchers funded by the National Institutes of Health Genotype-Tissue Expression (GTEx) project have created a new and much-anticipated data resource to help establish how differences in an individual's genomic make-up can affect gene activity and contribute to disease. The new resource will enable scientists to examine the underlying genomics of many different human tissues and cells at the same time, and promises to open new avenues to the study and understanding of human biology.

     

    More...

  • Three DOM Faculty Named as BSD Distinguished Faculty Award Winners

    Dr. Kenneth Polonsky, Dean of BSD and Executive Vice President for Medical Affairs recently announced the 2015 BSD Distinguished Faculty Award Winners. The group of award winners was selected from amongst many outstanding nominees in each of these categories by the members of the Faculty Advisory Committee, who carefully reviewed your nominations and voted to honor these individuals for their records of accomplishment here at the University of Chicago.

     

    More...

  • Monica Peek, MD

    Monica Peek, MD- Named Greenwall Foundation Scholar in Bioethics

    Monica Peek, MD, Associate Professor of Medicine (General Internal Medicine) has been selected by the Greenwall Foundation as a Greenwall Faculty Scholar for the class of 2018. Dr. Peek's broad research interests include health disparities, particularly as related to chronic disease management and preventive health care.

     

    More...

  • Eugene B. Chang, MD

    The microbiome and the midnight snack: How gut microbes influence the body's clock

    Poor sleep has long been linked with changes to the metabolism. Disruption of the body's internal clock can lead to changes in appetite and cravings for unhealthy food, which in turn leads to more serious health problems like obesity, diabetes and heart disease.

     

    More...

  • DOM Researchers Highlighted by NHLBI

    Two department of Medicine faculty, Dr. Julian Solway (Pulmonary/Critical Care) and Dr. Nanduri Prabhakar (Emergency Medicine) are featured in a three part series focused on the Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases (CADET) program. Earlier this year, Dr. Solway and Dr. Prabhakar each received prestigious grants from NHLBI to develop novel medications to treat asthma and sleep apnea, respectively. The grants are designed to accelerate discovery of effective pharmaceutical treatments during the critical second stage of a drug's development, the period between the discovery of a potential new medication and the first round of human clinical trials.

     

    More...

  • Marhall Chin, MD, MPH

    Marshall Chin,MD- Installed as SGIM President

    Marshall Chin, MD, MPH, the Richard Parillo Family Professor of Healthcare Ethics (General Internal Medicine), was recently installed as president of the Society of General Internal Medicine (SGIM) at the SGIM national meeting in Toronto. As president , Dr. Chin will lead the 18-member governing board and support and promote the work of its more than 80 member-driven committees, taskforces and interest groups.

     

    More...

  • Arshiya Baig, MD, MPH

    Church-based diabetes education program leads to healthier lifestyles among Latino adults

    Latino adults with diabetes who participated in a church-based education program reported eating less high-fat food and exercising more after the conclusion of a pilot intervention by researchers from the University of Chicago Department of Medicine.

     

    More...

  • Esra Tasali, MD

    Effective sleep apnea treatment lowers diabetes risk

    Using a simple device for eight hours a night to treat sleep apnea can help people with prediabetes improve their blood sugar levels and may reduce the risk of progressing to diabetes, according to a new study published online in the April 21, 2015, issue of the American Journal of Respiratory and Critical Care Medicine.

     

    More...

  • Samuel Refetoff, MD

    Samuel Refetoff, MD - Receives DOM 2015 Distinguished Service Award

    In recognition of his outstanding contributions to the clinical, research and educational missions of the Department of Medicine, Dr. Samuel Refetoff, Frederick H. Rawson Professor of  Medicine (Section of Endocrinology, Diabetes and Metabolism) received the Department of Medicine’s Distinguished Service Award at Grand Rounds on Tuesday, April 14,2015.

     

    More...

  • Nanduri Prabhakar, PhD

    Breathless: How blood-oxygen levels regulate air intake

    Researchers have unraveled the elusive process by which small, highly vascular clusters of sensory cells in the carotid arteries "taste the blood," as a 1926 essay put it -- the initial step in regulating blood-oxygen levels.

     

    More...

  • Arlene Chapman,MD

    Arlene Chapman, MD- Appointed New Chief Section of Nephrology

    Dr. Arlene Chapman has been appointed as Professor of Medicine and Chief of Nephrology effective March 30, 2015. Dr. Chapman is currently serving as Professor of Medicine in the Renal Division at Emory University School of Medicine, Associate Program Director of the Renal Fellowship Training Program, and Program Director for the Clinical Research Network of the Atlanta Clinical and Translational Science Institute.

    More...

MESSAGE FROM THE CHAIR

Welcome to the Department of Medicine at the University of Chicago. Our department was the first department created when the medical school began over 80 years ago. It has evolved into the largest department not only in the medical school with over 345 full time faculty and research faculty but is the largest department in the University. The main missions of the Department of Medicine, scholarship, discovery, education and outstanding patient care, occur in a setting of multicultural and ethnic diversity. These missions are supported by exceptional faculty and trainees in the department. We believe you will quickly agree that the DOM's faculty, fellows and trainees very much represent the forefront of academic medicine –extraordinary people doing things to support the missions of our department. The result is a Department which reaches far beyond the walls of our medical school to improve humanity and health throughout our community and the world providing high quality patient care – and training of the next generation of leaders in medicine.